Dr. Peter Butler is interested in the pathophysiology of islet dysfunction and beta cell apoptosis in diabetes. He also studies the relationship between diabetes and pancreatic cancer, and actions of diabetes medications on pancreatic cancer risk.
Selected Cancer-Related Publications:
Butler PC, Dry S, Elashoff R. GLP-1-based therapy for diabetes: what you do not know can hurt you. Diabetes Care. 2010 Feb;33(2):453-5.
Butler AE, Galasso R, Matveyenko A, Rizza RA, Dry S, Butler PC. Pancreatic duct replication is increased with obesity and type 2 diabetes in humans. Diabetologia. 2010 Jan;53(1):21-6. Epub 2009 Oct 21.
Butler PC. Insulin glargine controversy: a tribute to the editorial team at Diabetologia. Diabetes. 2009 Nov;58(11):2427-8.
Matveyenko AV, Dry S, Cox HI, Moshtaghian A, Gurlo T, Galasso R, Butler AE, Butler PC. Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin. Diabetes. 2009 Jul;58(7):1604-15. Epub 2009 Apr 29.